Value Set epSOSActiveIngredient 2013‑06‑03

1.3.6.1.4.1.12559.11.10.1.3.1.42.24

Effective Date

2013‑06‑03

Other versions this id:

epSOSActiveIngredient201711 - as of 2017‑11‑07 14:06:21

Status

Draft

Version Label

January 2010

Name

epSOSActiveIngredient

Display Name

epSOSActiveIngredient

Description

The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies and Other Adverse Reactions Section of the patient Summary.

Source Code System

2.16.840.1.113883.6.73 - WHO ATC

Level/ Type	Code	Display Name	Code System
0‑L	A	ALIMENTARY TRACT AND METABOLISM	WHO ATC
0‑L	A01	STOMATOLOGICAL PREPARATIONS	WHO ATC
0‑L	A01A	STOMATOLOGICAL PREPARATIONS	WHO ATC
0‑L	A01AA	Caries prophylactic agents	WHO ATC
0‑L	A01AA01	sodium fluoride	WHO ATC
0‑L	A01AA02	sodium monofluorophosphate	WHO ATC
0‑L	A01AA03	olaflur	WHO ATC
0‑L	A01AA04	stannous fluoride	WHO ATC
0‑L	A01AA30	combinations	WHO ATC
0‑L	A01AA51	sodium fluoride, combinations	WHO ATC
0‑L	A01AB	Antiinfectives and antiseptics for local oral treatment	WHO ATC
0‑L	A01AB02	hydrogen peroxide	WHO ATC
0‑L	A01AB03	chlorhexidine	WHO ATC
0‑L	A01AB04	amphotericin B	WHO ATC
0‑L	A01AB05	polynoxylin	WHO ATC
0‑L	A01AB06	domiphen	WHO ATC
0‑L	A01AB07	oxyquinoline	WHO ATC
0‑L	A01AB08	neomycin	WHO ATC
0‑L	A01AB09	miconazole	WHO ATC
0‑L	A01AB10	natamycin	WHO ATC
0‑L	A01AB11	various	WHO ATC
0‑L	A01AB12	hexetidine	WHO ATC
0‑L	A01AB13	tetracycline	WHO ATC
0‑L	A01AB14	benzoxonium chloride	WHO ATC
0‑L	A01AB15	tibezonium iodide	WHO ATC
0‑L	A01AB16	mepartricin	WHO ATC
0‑L	A01AB17	metronidazole	WHO ATC
0‑L	A01AB18	clotrimazole	WHO ATC
0‑L	A01AB19	sodium perborate	WHO ATC
0‑L	A01AB21	chlortetracycline	WHO ATC
0‑L	A01AB22	doxycycline	WHO ATC
0‑L	A01AB23	minocycline	WHO ATC
0‑L	A01AC	Corticosteroids for local oral treatment	WHO ATC
0‑L	A01AC01	triamcinolone	WHO ATC
0‑L	A01AC02	dexamethasone	WHO ATC
0‑L	A01AC03	hydrocortisone	WHO ATC
0‑L	A01AC54	prednisolone, combinations	WHO ATC
0‑L	A01AD	Other agents for local oral treatment	WHO ATC
0‑L	A01AD01	epinephrine	WHO ATC
0‑L	A01AD02	benzydamine	WHO ATC
0‑L	A01AD05	acetylsalicylic acid	WHO ATC
0‑L	A01AD06	adrenalone	WHO ATC
0‑L	A01AD07	amlexanox	WHO ATC
0‑L	A01AD08	becaplermin	WHO ATC
0‑L	A01AD11	various	WHO ATC
0‑L	A02	DRUGS FOR ACID RELATED DISORDERS	WHO ATC
0‑L	A02A	ANTACIDS	WHO ATC
0‑L	A02AA	Magnesium compounds	WHO ATC
0‑L	A02AA01	magnesium carbonate	WHO ATC
0‑L	A02AA02	magnesium oxide	WHO ATC
0‑L	A02AA03	magnesium peroxide	WHO ATC
0‑L	A02AA04	magnesium hydroxide	WHO ATC
0‑L	A02AA05	magnesium silicate	WHO ATC
0‑L	A02AA10	combinations	WHO ATC
0‑L	A02AB	Aluminium compounds	WHO ATC
0‑L	A02AB01	aluminium hydroxide	WHO ATC
0‑L	A02AB02	algeldrate	WHO ATC
0‑L	A02AB03	aluminium phosphate	WHO ATC
0‑L	A02AB04	dihydroxialumini sodium carbonate	WHO ATC
0‑L	A02AB05	aluminium acetoacetate	WHO ATC
0‑L	A02AB06	aloglutamol	WHO ATC
0‑L	A02AB07	aluminium glycinate	WHO ATC
0‑L	A02AB10	combinations	WHO ATC
0‑L	A02AC	Calcium compounds	WHO ATC
0‑L	A02AC01	calcium carbonate	WHO ATC
0‑L	A02AC02	calcium silicate	WHO ATC
0‑L	A02AC10	combinations	WHO ATC
0‑L	A02AD	Combinations and complexes of aluminium, calcium and magnesium compounds	WHO ATC
0‑L	A02AD01	ordinary salt combinations	WHO ATC
0‑L	A02AD02	magaldrate	WHO ATC
0‑L	A02AD03	almagate	WHO ATC
0‑L	A02AD04	hydrotalcite	WHO ATC
0‑L	A02AD05	almasilate	WHO ATC
0‑L	A02AF	Antacids with antiflatulents	WHO ATC
0‑L	A02AF01	magaldrate and antiflatulents	WHO ATC
0‑L	A02AF02	ordinary salt combinations and antiflatulents	WHO ATC
0‑L	A02AG	Antacids with antispasmodics	WHO ATC
0‑L	A02AH	Antacids with sodium bicarbonate	WHO ATC
0‑L	A02AX	Antacids, other combinations	WHO ATC
0‑L	A02B	DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)	WHO ATC
0‑L	A02BA	H2-receptor antagonists	WHO ATC
0‑L	A02BA01	cimetidine	WHO ATC
0‑L	A02BA02	ranitidine	WHO ATC
0‑L	A02BA03	famotidine	WHO ATC
0‑L	A02BA04	nizatidine	WHO ATC
0‑L	A02BA05	niperotidine	WHO ATC
0‑L	A02BA06	roxatidine	WHO ATC
0‑L	A02BA07	ranitidine bismuth citrate	WHO ATC
0‑L	A02BA08	lafutidine	WHO ATC
0‑L	A02BA51	cimetidine, combinations	WHO ATC
0‑L	A02BA53	famotidine, combinations	WHO ATC
0‑L	A02BB	Prostaglandins	WHO ATC
0‑L	A02BB01	misoprostol	WHO ATC
0‑L	A02BB02	enprostil	WHO ATC
0‑L	A02BC	Proton pump inhibitors	WHO ATC
0‑L	A02BC01	omeprazole	WHO ATC
0‑L	A02BC02	pantoprazole	WHO ATC
0‑L	A02BC03	lansoprazole	WHO ATC
0‑L	A02BC04	rabeprazole	WHO ATC
0‑L	A02BC05	esomeprazole	WHO ATC
0‑L	A02BD	Combinations for eradication of Helicobacter pylori	WHO ATC
0‑L	A02BD01	omeprazole, amoxicillin and metronidazole	WHO ATC
0‑L	A02BD02	lansoprazole, tetracycline and metronidazole	WHO ATC
0‑L	A02BD03	lansoprazole, amoxicillin and metronidazole	WHO ATC
0‑L	A02BD04	pantoprazole, amoxicillin and clarithromycin	WHO ATC
0‑L	A02BD05	omeprazole, amoxicillin and clarithromycin	WHO ATC
0‑L	A02BD06	esomeprazole, amoxicillin and clarithromycin	WHO ATC
0‑L	A02BD07	lansoprazole, amoxicillin and clarithromycin	WHO ATC
0‑L	A02BX	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	WHO ATC
0‑L	A02BX01	carbenoxolone	WHO ATC
0‑L	A02BX02	sucralfate	WHO ATC
0‑L	A02BX03	pirenzepine	WHO ATC
0‑L	A02BX04	methiosulfonium chloride	WHO ATC
0‑L	A02BX05	bismuth subcitrate	WHO ATC
0‑L	A02BX06	proglumide	WHO ATC
0‑L	A02BX07	gefarnate	WHO ATC
0‑L	A02BX08	sulglicotide	WHO ATC
0‑L	A02BX09	acetoxolone	WHO ATC
0‑L	A02BX10	zolimidine	WHO ATC
0‑L	A02BX11	troxipide	WHO ATC
0‑L	A02BX12	bismuth subnitrate	WHO ATC
0‑L	A02BX13	alginic acid	WHO ATC
0‑L	A02BX51	carbenoxolone, combinations excl. psycholeptics	WHO ATC
0‑L	A02BX71	carbenoxolone, combinations with psycholeptics	WHO ATC
0‑L	A02BX77	gefarnate, combinations with psycholeptics	WHO ATC
0‑L	A02X	OTHER DRUGS FOR ACID RELATED DISORDERS	WHO ATC
0‑L	A03	DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS	WHO ATC
0‑L	A03A	DRUGS FOR FUNCTIONAL BOWEL DISORDERS	WHO ATC
0‑L	A03AA	Synthetic anticholinergics, esters with tertiary amino group	WHO ATC
0‑L	A03AA01	oxyphencyclimine	WHO ATC
0‑L	A03AA03	camylofin	WHO ATC
0‑L	A03AA04	mebeverine	WHO ATC
0‑L	A03AA05	trimebutine	WHO ATC
0‑L	A03AA06	rociverine	WHO ATC
0‑L	A03AA07	dicycloverine	WHO ATC
0‑L	A03AA08	dihexyverine	WHO ATC
0‑L	A03AA09	difemerine	WHO ATC
0‑L	A03AA30	piperidolate	WHO ATC
0‑L	A03AB	Synthetic anticholinergics, quaternary ammonium compounds	WHO ATC
0‑L	A03AB01	benzilone	WHO ATC
0‑L	A03AB02	glycopyrronium	WHO ATC
0‑L	A03AB03	oxyphenonium	WHO ATC
0‑L	A03AB04	penthienate	WHO ATC
0‑L	A03AB05	propantheline	WHO ATC
0‑L	A03AB06	otilonium bromide	WHO ATC
0‑L	A03AB07	methantheline	WHO ATC
0‑L	A03AB08	tridihexethyl	WHO ATC
0‑L	A03AB09	isopropamide	WHO ATC
0‑L	A03AB10	hexocyclium	WHO ATC
0‑L	A03AB11	poldine	WHO ATC
0‑L	A03AB12	mepenzolate	WHO ATC
0‑L	A03AB13	bevonium	WHO ATC
0‑L	A03AB14	pipenzolate	WHO ATC
0‑L	A03AB15	diphemanil	WHO ATC
0‑L	A03AB16	(2-benzhydryloxyethyl)diethyl-methylammonium iodide	WHO ATC
0‑L	A03AB17	tiemonium iodide	WHO ATC
0‑L	A03AB18	prifinium bromide	WHO ATC
0‑L	A03AB19	timepidium bromide	WHO ATC
0‑L	A03AB21	fenpiverinium	WHO ATC
0‑L	A03AB53	oxyphenonium, combinations	WHO ATC
0‑L	A03AC	Synthetic antispasmodics, amides with tertiary amines	WHO ATC
0‑L	A03AC02	dimethylaminopropionylphenothiazine	WHO ATC
0‑L	A03AC04	nicofetamide	WHO ATC
0‑L	A03AC05	tiropramide	WHO ATC
0‑L	A03AD	Papaverine and derivatives	WHO ATC
0‑L	A03AD01	papaverine	WHO ATC
0‑L	A03AD02	drotaverine	WHO ATC
0‑L	A03AD30	moxaverine	WHO ATC
0‑L	A03AE	Drugs acting on serotonin receptors	WHO ATC
0‑L	A03AE01	alosetron	WHO ATC
0‑L	A03AE02	tegaserod	WHO ATC
0‑L	A03AE03	cilansetron	WHO ATC
0‑L	A03AE04	prucalopride	WHO ATC
0‑L	A03AX	Other drugs for functional bowel disorders	WHO ATC
0‑L	A03AX01	fenpiprane	WHO ATC
0‑L	A03AX02	diisopromine	WHO ATC
0‑L	A03AX03	chlorbenzoxamine	WHO ATC
0‑L	A03AX04	pinaverium	WHO ATC
0‑L	A03AX05	fenoverine	WHO ATC
0‑L	A03AX06	idanpramine	WHO ATC
0‑L	A03AX07	proxazole	WHO ATC
0‑L	A03AX08	alverine	WHO ATC
0‑L	A03AX09	trepibutone	WHO ATC
0‑L	A03AX10	isometheptene	WHO ATC
0‑L	A03AX11	caroverine	WHO ATC
0‑L	A03AX12	phloroglucinol	WHO ATC
0‑L	A03AX13	silicones	WHO ATC
0‑L	A03AX30	trimethyldiphenylpropylamine	WHO ATC
0‑L	A03AX58	alverine, combinations	WHO ATC
0‑L	A03B	BELLADONNA AND DERIVATIVES, PLAIN	WHO ATC
0‑L	A03BA	Belladonna alkaloids, tertiary amines	WHO ATC
0‑L	A03BA01	atropine	WHO ATC
0‑L	A03BA03	hyoscyamine	WHO ATC
0‑L	A03BA04	belladonna total alkaloids	WHO ATC
0‑L	A03BB	Belladonna alkaloids, semisynthetic, quaternary ammonium compounds	WHO ATC
0‑L	A03BB01	butylscopolamine	WHO ATC
0‑L	A03BB02	methylatropine	WHO ATC
0‑L	A03BB03	methylscopolamine	WHO ATC
0‑L	A03BB04	fentonium	WHO ATC
0‑L	A03BB05	cimetropium bromide	WHO ATC
0‑L	A03C	ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS	WHO ATC
0‑L	A03CA	Synthetic anticholinergic agents in combination with psycholeptics	WHO ATC
0‑L	A03CA01	isopropamide and psycholeptics	WHO ATC
0‑L	A03CA02	clidinium and psycholeptics	WHO ATC
0‑L	A03CA03	oxyphencyclimine and psycholeptics	WHO ATC
0‑L	A03CA04	otilonium bromide and psycholeptics	WHO ATC
0‑L	A03CA05	glycopyrronium and psycholeptics	WHO ATC
0‑L	A03CA06	bevonium and psycholeptics	WHO ATC
0‑L	A03CA07	ambutonium and psycholeptics	WHO ATC
0‑L	A03CA08	diphemanil and psycholeptics	WHO ATC
0‑L	A03CA30	emepronium and psycholeptics	WHO ATC
0‑L	A03CA34	propantheline and psycholeptics	WHO ATC
0‑L	A03CB	Belladonna and derivatives in combination with psycholeptics	WHO ATC
0‑L	A03CB01	methylscopolamine and psycholeptics	WHO ATC
0‑L	A03CB02	belladonna total alkaloids and psycholeptics	WHO ATC
0‑L	A03CB03	atropine and psycholeptics	WHO ATC
0‑L	A03CB04	methylhomatropine and psycholeptics	WHO ATC
0‑L	A03CB31	hyoscyamine and psycholeptics	WHO ATC
0‑L	A03CC	Other antispasmodics in combination with psycholeptics	WHO ATC
0‑L	A03D	ANTISPASMODICS IN COMBINATION WITH ANALGESICS	WHO ATC
0‑L	A03DA	Synthetic anticholinergic agents in combination with analgesics	WHO ATC
0‑L	A03DA01	tropenzilone and analgesics	WHO ATC
0‑L	A03DA02	pitofenone and analgesics	WHO ATC
0‑L	A03DA03	bevonium and analgesics	WHO ATC
0‑L	A03DA04	ciclonium and analgesics	WHO ATC
0‑L	A03DA05	camylofin and analgesics	WHO ATC
0‑L	A03DA06	trospium and analgesics	WHO ATC
0‑L	A03DA07	tiemonium iodide and analgesics	WHO ATC
0‑L	A03DB	Belladonna and derivatives in combination with analgesics	WHO ATC
0‑L	A03DB04	butylscopolamine and analgesics	WHO ATC
0‑L	A03DC	Other antispasmodics in combination with analgesics	WHO ATC
0‑L	A03E	ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS	WHO ATC
0‑L	A03EA	Antispasmodics, psycholeptics and analgesics in combination	WHO ATC
0‑L	A03ED	Antispasmodics in combination with other drugs	WHO ATC
0‑L	A03F	PROPULSIVES	WHO ATC
0‑L	A03FA	Propulsives	WHO ATC
0‑L	A03FA01	metoclopramide	WHO ATC
0‑L	A03FA02	cisapride	WHO ATC
0‑L	A03FA03	domperidone	WHO ATC
0‑L	A03FA04	bromopride	WHO ATC
0‑L	A03FA05	alizapride	WHO ATC
0‑L	A03FA06	clebopride	WHO ATC
0‑L	A04	ANTIEMETICS AND ANTINAUSEANTS	WHO ATC
0‑L	A04A	ANTIEMETICS AND ANTINAUSEANTS	WHO ATC
0‑L	A04AA	Serotonin (5HT3) antagonists	WHO ATC
0‑L	A04AA01	ondansetron	WHO ATC
0‑L	A04AA02	granisetron	WHO ATC
0‑L	A04AA03	tropisetron	WHO ATC
0‑L	A04AA04	dolasetron	WHO ATC
0‑L	A04AA05	palonosetron	WHO ATC
0‑L	A04AD	Other antiemetics	WHO ATC
0‑L	A04AD01	scopolamine	WHO ATC
0‑L	A04AD02	cerium oxalate	WHO ATC
0‑L	A04AD04	chlorobutanol	WHO ATC
0‑L	A04AD05	metopimazine	WHO ATC
0‑L	A04AD10	dronabinol	WHO ATC
0‑L	A04AD11	nabilone	WHO ATC
0‑L	A04AD12	aprepitant	WHO ATC
0‑L	A04AD13	casopitant	WHO ATC
0‑L	A04AD51	scopolamine, combinations	WHO ATC
0‑L	A04AD54	chlorobutanol, combinations	WHO ATC
0‑L	A05	BILE AND LIVER THERAPY	WHO ATC
0‑L	A05A	BILE THERAPY	WHO ATC
0‑L	A05AA	Bile acid preparations	WHO ATC
0‑L	A05AA01	chenodeoxycholic acid	WHO ATC
0‑L	A05AA02	ursodeoxycholic acid	WHO ATC
0‑L	A05AA03	cholic acid	WHO ATC
0‑L	A05AB	Preparations for biliary tract therapy	WHO ATC
0‑L	A05AB01	nicotinyl methylamide	WHO ATC
0‑L	A05AX	Other drugs for bile therapy	WHO ATC
0‑L	A05AX01	piprozolin	WHO ATC
0‑L	A05AX02	hymecromone	WHO ATC
0‑L	A05AX03	cyclobutyrol	WHO ATC
0‑L	A05B	LIVER THERAPY, LIPOTROPICS	WHO ATC
0‑L	A05BA	Liver therapy	WHO ATC
0‑L	A05BA01	arginine glutamate	WHO ATC
0‑L	A05BA03	silymarin	WHO ATC
0‑L	A05BA04	citiolone	WHO ATC
0‑L	A05BA05	epomediol	WHO ATC
0‑L	A05BA06	ornithine oxoglurate	WHO ATC
0‑L	A05BA07	tidiacic arginine	WHO ATC
0‑L	A05BA08	glycyrrhizic acid	WHO ATC
0‑L	A05C	DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION	WHO ATC
0‑L	A06	LAXATIVES	WHO ATC
0‑L	A06A	LAXATIVES	WHO ATC
0‑L	A06AA	Softeners, emollients	WHO ATC
0‑L	A06AA01	liquid paraffin	WHO ATC
0‑L	A06AA02	docusate sodium	WHO ATC
0‑L	A06AA51	liquid paraffin, combinations	WHO ATC
0‑L	A06AB	Contact laxatives	WHO ATC
0‑L	A06AB01	oxyphenisatine	WHO ATC
0‑L	A06AB02	bisacodyl	WHO ATC
0‑L	A06AB03	dantron	WHO ATC
0‑L	A06AB04	phenolphthalein	WHO ATC
0‑L	A06AB05	castor oil	WHO ATC
0‑L	A06AB06	senna glycosides	WHO ATC
0‑L	A06AB07	cascara	WHO ATC
0‑L	A06AB08	sodium picosulfate	WHO ATC
0‑L	A06AB09	bisoxatin	WHO ATC
0‑L	A06AB20	contact laxatives in combination	WHO ATC
0‑L	A06AB30	contact laxatives in combination with belladonna alkaloids	WHO ATC
0‑L	A06AB52	bisacodyl, combinations	WHO ATC
0‑L	A06AB53	dantron, combinations	WHO ATC
0‑L	A06AB56	senna glycosides, combinations	WHO ATC
0‑L	A06AB57	cascara, combinations	WHO ATC
0‑L	A06AB58	sodium picosulfate, combinations	WHO ATC
0‑L	A06AC	Bulk producers	WHO ATC
0‑L	A06AC01	ispaghula (psylla seeds)	WHO ATC
0‑L	A06AC02	ethulose	WHO ATC
0‑L	A06AC03	sterculia	WHO ATC
0‑L	A06AC05	linseed	WHO ATC
0‑L	A06AC06	methylcellulose	WHO ATC
0‑L	A06AC07	triticum (wheat fibre)	WHO ATC
0‑L	A06AC08	polycarbophil calcium	WHO ATC
0‑L	A06AC51	ispaghula, combinations	WHO ATC
0‑L	A06AC53	sterculia, combinations	WHO ATC
0‑L	A06AC55	linseed, combinations	WHO ATC
0‑L	A06AD	Osmotically acting laxatives	WHO ATC
0‑L	A06AD01	magnesium carbonate	WHO ATC
0‑L	A06AD02	magnesium oxide	WHO ATC
0‑L	A06AD03	magnesium peroxide	WHO ATC
0‑L	A06AD04	magnesium sulfate	WHO ATC
0‑L	A06AD10	mineral salts in combination	WHO ATC
0‑L	A06AD11	lactulose	WHO ATC
0‑L	A06AD12	lactitol	WHO ATC
0‑L	A06AD13	sodium sulfate	WHO ATC
0‑L	A06AD14	pentaerithrityl	WHO ATC
0‑L	A06AD15	macrogol	WHO ATC
0‑L	A06AD16	mannitol	WHO ATC
0‑L	A06AD17	sodium phosphate	WHO ATC
0‑L	A06AD18	sorbitol	WHO ATC
0‑L	A06AD19	magnesium citrate	WHO ATC
0‑L	A06AD21	sodium tartrate	WHO ATC
0‑L	A06AD61	lactulose, combinations	WHO ATC
0‑L	A06AD65	macrogol, combinations	WHO ATC
0‑L	A06AG	Enemas	WHO ATC
0‑L	A06AG01	sodium phosphate	WHO ATC
0‑L	A06AG02	bisacodyl	WHO ATC
0‑L	A06AG03	dantron, incl. combinations	WHO ATC
0‑L	A06AG04	glycerol	WHO ATC
0‑L	A06AG06	oil	WHO ATC
0‑L	A06AG07	sorbitol	WHO ATC
0‑L	A06AG10	docusate sodium, incl. combinations	WHO ATC
0‑L	A06AG11	laurilsulfate, incl. combinations	WHO ATC
0‑L	A06AG20	combinations	WHO ATC
0‑L	A06AH	Peripheral opioid receptor antagonists	WHO ATC
0‑L	A06AH01	methylnaltrexone bromide	WHO ATC
0‑L	A06AH02	alvimopan	WHO ATC
0‑L	A06AX	Other laxatives	WHO ATC
0‑L	A06AX01	glycerol	WHO ATC
0‑L	A06AX02	carbon dioxide producing drugs	WHO ATC
0‑L	A06AX03	lubiprostone	WHO ATC
0‑L	A07	ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVEAGENTS	WHO ATC
0‑L	A07A	INTESTINAL ANTIINFECTIVES	WHO ATC
0‑L	A07AA	Antibiotics	WHO ATC
0‑L	A07AA01	neomycin	WHO ATC
0‑L	A07AA02	nystatin	WHO ATC
0‑L	A07AA03	natamycin	WHO ATC
0‑L	A07AA04	streptomycin	WHO ATC
0‑L	A07AA05	polymyxin B	WHO ATC
0‑L	A07AA06	paromomycin	WHO ATC
0‑L	A07AA07	amphotericin B	WHO ATC
0‑L	A07AA08	kanamycin	WHO ATC
0‑L	A07AA09	vancomycin	WHO ATC
0‑L	A07AA10	colistin	WHO ATC
0‑L	A07AA11	rifaximin	WHO ATC
0‑L	A07AA51	neomycin, combinations	WHO ATC
0‑L	A07AA54	streptomycin, combinations	WHO ATC
0‑L	A07AB	Sulfonamides	WHO ATC
0‑L	A07AB02	phthalylsulfathiazole	WHO ATC
0‑L	A07AB03	sulfaguanidine	WHO ATC
0‑L	A07AB04	succinylsulfathiazole	WHO ATC
0‑L	A07AC	Imidazole derivatives	WHO ATC
0‑L	A07AC01	miconazole	WHO ATC
0‑L	A07AX	Other intestinal antiinfectives	WHO ATC
0‑L	A07AX01	broxyquinoline	WHO ATC
0‑L	A07AX02	acetarsol	WHO ATC
0‑L	A07AX03	nifuroxazide	WHO ATC
0‑L	A07AX04	nifurzide	WHO ATC
0‑L	A07B	INTESTINAL ADSORBENTS	WHO ATC
0‑L	A07BA	Charcoal preparations	WHO ATC
0‑L	A07BA01	medicinal charcoal	WHO ATC
0‑L	A07BA51	medicinal charcoal, combinations	WHO ATC
0‑L	A07BB	Bismuth preparations	WHO ATC
0‑L	A07BC	Other intestinal adsorbents	WHO ATC
0‑L	A07BC01	pectin	WHO ATC
0‑L	A07BC02	kaolin	WHO ATC
0‑L	A07BC03	crospovidone	WHO ATC
0‑L	A07BC04	attapulgite	WHO ATC
0‑L	A07BC05	diosmectite	WHO ATC
0‑L	A07BC30	combinations	WHO ATC
0‑L	A07BC54	attapulgite, combinations	WHO ATC
0‑L	A07C	ELECTROLYTES WITH CARBOHYDRATES	WHO ATC
0‑L	A07CA	Oral rehydration salt formulations	WHO ATC
0‑L	A07D	ANTIPROPULSIVES	WHO ATC
0‑L	A07DA	Antipropulsives	WHO ATC
0‑L	A07DA01	diphenoxylate	WHO ATC
0‑L	A07DA02	opium	WHO ATC
0‑L	A07DA03	loperamide	WHO ATC
0‑L	A07DA04	difenoxin	WHO ATC
0‑L	A07DA05	loperamide oxide	WHO ATC
0‑L	A07DA52	morphine, combinations	WHO ATC
0‑L	A07DA53	loperamide, combinations	WHO ATC
0‑L	A07E	INTESTINAL ANTIINFLAMMATORY AGENTS	WHO ATC
0‑L	A07EA	Corticosteroids acting locally	WHO ATC
0‑L	A07EA01	prednisolone	WHO ATC
0‑L	A07EA02	hydrocortisone	WHO ATC
0‑L	A07EA03	prednisone	WHO ATC
0‑L	A07EA04	betamethasone	WHO ATC
0‑L	A07EA05	tixocortol	WHO ATC
0‑L	A07EA06	budesonide	WHO ATC
0‑L	A07EA07	beclometasone	WHO ATC
0‑L	A07EB	Antiallergic agents, excl. corticosteroids	WHO ATC
0‑L	A07EB01	cromoglicic acid	WHO ATC
0‑L	A07EC	Aminosalicylic acid and similar agents	WHO ATC
0‑L	A07EC01	sulfasalazine	WHO ATC
0‑L	A07EC02	mesalazine	WHO ATC
0‑L	A07EC03	olsalazine	WHO ATC
0‑L	A07EC04	balsalazide	WHO ATC
0‑L	A07F	ANTIDIARRHEAL MICROORGANISMS	WHO ATC
0‑L	A07FA	Antidiarrheal microorganisms	WHO ATC
0‑L	A07FA01	lactic acid producing organisms	WHO ATC
0‑L	A07FA02	saccharomyces boulardii	WHO ATC
0‑L	A07FA51	lactic acid producing organisms, combinations	WHO ATC
0‑L	A07X	OTHER ANTIDIARRHEALS	WHO ATC
0‑L	A07XA	Other antidiarrheals	WHO ATC
0‑L	A07XA01	albumin tannate	WHO ATC
0‑L	A07XA02	ceratonia	WHO ATC
0‑L	A07XA03	calcium compounds	WHO ATC
0‑L	A07XA04	racecadotril	WHO ATC
0‑L	A07XA51	albumin tannate, combinations	WHO ATC
0‑L	A08	ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS	WHO ATC
0‑L	A08A	ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS	WHO ATC
0‑L	A08AA	Centrally acting antiobesity products	WHO ATC
0‑L	A08AA01	phentermine	WHO ATC
0‑L	A08AA02	fenfluramine	WHO ATC
0‑L	A08AA03	amfepramone	WHO ATC
0‑L	A08AA04	dexfenfluramine	WHO ATC
0‑L	A08AA05	mazindol	WHO ATC
0‑L	A08AA06	etilamfetamine	WHO ATC
0‑L	A08AA07	cathine	WHO ATC
0‑L	A08AA08	clobenzorex	WHO ATC
0‑L	A08AA09	mefenorex	WHO ATC
0‑L	A08AA10	sibutramine	WHO ATC
0‑L	A08AA56	ephedrine, combinations	WHO ATC
0‑L	A08AB	Peripherally acting antiobesity products	WHO ATC
0‑L	A08AB01	orlistat	WHO ATC
0‑L	A08AX	Other antiobesity drugs	WHO ATC
0‑L	A08AX01	rimonabant	WHO ATC
0‑L	A09	DIGESTIVES, INCL. ENZYMES	WHO ATC
0‑L	A09A	DIGESTIVES, INCL. ENZYMES	WHO ATC
0‑L	A09AA	Enzyme preparations	WHO ATC
0‑L	A09AA01	diastase	WHO ATC
0‑L	A09AA02	multienzymes (lipase, protease etc.)	WHO ATC
0‑L	A09AA03	pepsin	WHO ATC
0‑L	A09AA04	tilactase	WHO ATC
0‑L	A09AB	Acid preparations	WHO ATC
0‑L	A09AB01	glutamic acid hydrochloride	WHO ATC
0‑L	A09AB02	betaine hydrochloride	WHO ATC
0‑L	A09AB03	hydrochloric acid	WHO ATC
0‑L	A09AB04	citric acid	WHO ATC
0‑L	A09AC	Enzyme and acid preparations, combinations	WHO ATC
0‑L	A09AC01	pepsin and acid preparations	WHO ATC
0‑L	A09AC02	multienzymes and acid preparations	WHO ATC
0‑L	A10	DRUGS USED IN DIABETES	WHO ATC
0‑L	A10A	INSULINS AND ANALOGUES	WHO ATC
0‑L	A10AB	Insulins and analogues for injection, fast-acting	WHO ATC
0‑L	A10AB01	insulin (human)	WHO ATC
0‑L	A10AB02	insulin (beef)	WHO ATC
0‑L	A10AB03	insulin (pork)	WHO ATC
0‑L	A10AB04	insulin lispro	WHO ATC
0‑L	A10AB05	insulin aspart	WHO ATC
0‑L	A10AB06	insulin glulisine	WHO ATC
0‑L	A10AB30	combinations	WHO ATC
0‑L	A10AC	Insulins and analogues for injection, intermediate-acting	WHO ATC
0‑L	A10AC01	insulin (human)	WHO ATC
0‑L	A10AC02	insulin (beef)	WHO ATC
0‑L	A10AC03	insulin (pork)	WHO ATC
0‑L	A10AC04	insulin lispro	WHO ATC
0‑L	A10AC30	combinations	WHO ATC
0‑L	A10AD	Insulins and analogues for injection, intermediate-acting combined with fast-acting	WHO ATC
0‑L	A10AD01	insulin (human)	WHO ATC
0‑L	A10AD02	insulin (beef)	WHO ATC
0‑L	A10AD03	insulin (pork)	WHO ATC
0‑L	A10AD04	Insulin lispro	WHO ATC
0‑L	A10AD05	insulin aspart	WHO ATC
0‑L	A10AD30	combinations	WHO ATC
0‑L	A10AE	Insulins and analogues for injection, long-acting	WHO ATC
0‑L	A10AE01	insulin (human)	WHO ATC
0‑L	A10AE02	insulin (beef)	WHO ATC
0‑L	A10AE03	insulin (pork)	WHO ATC
0‑L	A10AE04	insulin glargine	WHO ATC
0‑L	A10AE05	insulin detemir	WHO ATC
0‑L	A10AE30	combinations	WHO ATC
0‑L	A10AF	Insulins and analogues for inhalation	WHO ATC
0‑L	A10AF01	insulin (human)	WHO ATC
0‑L	A10B	BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS	WHO ATC
0‑L	A10BA	Biguanides	WHO ATC
0‑L	A10BA01	phenformin	WHO ATC
This value set has 5592 codes in it. In order to keep the publication size manageable, only a selection (500 codes) of the whole set of codes is shown.

Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.

XML JSON CSV SQL SVS